US Corporate Distress Financial Stress SEC Filings — February 03, 2026

04-02-2026

Cooper Companies, Inc. filed an 8-K on February 4, 2026, disclosing entry into a material definitive agreement under Item 1.01, with financial statements and exhibits provided under Item 9.01. No specific details on the agreement's nature, parties, dollar value, or financial impacts are disclosed. This is a multi-item filing focused on a material event, but lacks quantitative metrics or comparisons.

04-02-2026

Silicon Laboratories Inc. filed an 8-K on February 4, 2026, reporting entry into a material definitive agreement under Item 1.01 and Regulation FD disclosure under Item 7.01, with financial statements and exhibits under Item 9.01. This is a multi-item mandatory filing for the material agreement, likely filed timely within 4 business days. Specific details on the agreement, transaction value, parties, financial impacts, or other metrics are NOT_DISCLOSED.

04-02-2026

Medalist Diversified REIT, Inc. filed an 8-K on February 4, 2026 (AccNo: 0001104659-26-010034), reporting entry into a material definitive agreement under Item 1.01, with exhibits attached under Item 9.01. No specific details on the agreement terms, parties, transaction value, financial impacts, or strategic rationale are disclosed in the provided filing summary. This is a multi-item mandatory disclosure of a material event.

04-02-2026

Functional Brands Inc. filed a Form 8-K on February 4, 2026, under Item 3.03 disclosing material modifications to rights of security holders. Item 9.01 lists financial statements and exhibits. No specific details on the modifications, financial impacts, dollar values, or quantitative metrics were provided.

04-02-2026

Fusemachines Inc. filed an 8-K on 2026-02-04 disclosing under Item 1.01 entry into a material definitive agreement. Item 9.01 includes financial statements and exhibits. No details on the agreement terms, parties, financial impacts, or metrics are disclosed.

04-02-2026

Entera Bio Ltd. filed a Form 8-K on 2026-02-04 disclosing entry into a material definitive agreement under Item 1.01, departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements under Item 5.02, Regulation FD disclosure under Item 7.01, and financial statements and exhibits under Item 9.01. No quantitative financial metrics, transaction details, personnel names, or directional impacts (positive or negative) were specified. This is a multi-item informational filing with no disclosed period-over-period comparisons or flat performance indicators.

04-02-2026

PAVmed Inc. filed a multi-item Form 8-K on February 4, 2026, disclosing entry into a material definitive agreement (Item 1.01) and termination of another (Item 1.02), alongside creation of a direct financial obligation (Item 2.03), unregistered sales of equity securities (Item 3.02), material modifications to security holder rights (Item 3.03), amendments to articles of incorporation or bylaws (Item 5.03), and Regulation FD disclosure (Item 7.01). No quantitative details such as transaction values, share counts, or financial impacts are provided in the filing summary. These events suggest potential restructuring or financing activities, but lack of specifics limits assessment of net positive or negative implications.

04-02-2026

Sangamo Therapeutics, Inc. filed a Form 8-K on 2026-02-04 reporting entry into a material definitive agreement under Item 1.01 and unregistered sales of equity securities under Item 3.02, with exhibits under Item 9.01. The filing represents a multi-item disclosure of a potentially strategic transaction but also potential share dilution from equity sales. No specific transaction values, share counts, financial impacts, or strategic details are disclosed.

04-02-2026

Cuentas Inc. filed a multi-item Form 8-K on February 4, 2026, disclosing entry into a material definitive agreement under Item 1.01 and material modifications to rights of security holders under Item 3.03, alongside Regulation FD disclosure (Item 7.01), other events (Item 8.01), and financial statements/exhibits (Item 9.01). The filing lacks specific details on transaction terms, financial impacts, or quantitative metrics. Modifications to shareholder rights may introduce dilution risks, while the new agreement could signal strategic opportunities.

04-02-2026

International Land Alliance Inc. filed a Form 8-K on February 4, 2026, reporting under Item 3.03 material modifications to rights of security holders, Item 5.03 amendments to articles of incorporation or bylaws or change in fiscal year, Item 5.07 submission of matters to a vote of security holders, Item 8.01 other events, and Item 9.01 financial statements and exhibits. No quantitative financial metrics, transaction values, or period-over-period comparisons are disclosed. This multi-item filing provides governance and shareholder-related updates without specified positive or negative impacts.

04-02-2026

CECO Environmental Corp filed an 8-K on 2026-02-04 reporting entry into a Material Definitive Agreement under Item 1.01 and creation of a Direct Financial Obligation or Off-Balance Sheet Arrangement under Item 2.03. Item 9.01 provides Financial Statements and Exhibits. No quantitative details, terms, positive or negative metrics, or directional impacts are disclosed.

• ·AccNo: 0001193125-26-036815
• ·File Size: 2 MB
• ·Multi-item mandatory 8-K filing

04-02-2026

VSE Corp filed an 8-K on 2026-02-04 (AccNo: 0001193125-26-036858) reporting Item 1.01 Entry into a Material Definitive Agreement and Item 9.01 Financial Statements and Exhibits. No specific details on the agreement terms, transaction value, financial impacts, or other metrics are disclosed. This is a multi-item mandatory filing with no quantitative data provided.

04-02-2026

Company filed an 8-K on 2026-02-04 disclosing entry into a Material Definitive Agreement under Item 1.01 and creation of a Direct Financial Obligation or Off-Balance Sheet Arrangement under Item 2.03, with exhibits under Item 9.01. This is a multi-item mandatory filing likely within the required 4-business-day window given the same-day event and filing dates. No quantitative details, dollar values, strategic context, or financial impacts are disclosed in the provided information.

04-02-2026

OKMIN RESOURCES, INC. filed a Form 8-K on 2026-02-04 disclosing under Item 1.01 entry into a material definitive agreement and under Item 9.01 financial statements and exhibits (AccNo: 0001079973-26-000165, Size: 677 KB). No details on the agreement, transaction value, parties, financial impacts, or metrics are provided in the filing summary. This is a multi-item mandatory disclosure of a material event.

04-02-2026

Workday, Inc. filed a Form 8-K on 2026-02-04 under Item 2.02 (Results of Operations and Financial Condition), Item 2.05 (Costs Associated with Exit or Disposal Activities), and Item 2.06 (Material Impairments), indicating a multi-item disclosure. While results of operations may include performance updates, the presence of exit/disposal costs and material impairments points to negative financial pressures such as restructuring and asset write-downs. Specific metrics, dollar values, or period-over-period comparisons are NOT_DISCLOSED.

04-02-2026

SUNation Energy, Inc. filed an 8-K on 2026-02-04 reporting Item 1.01 (Entry into a Material Definitive Agreement), Item 2.03 (Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). Specific details on the nature of the agreement, financial obligation, transaction value, or any quantitative impacts are NOT_DISCLOSED. No revenue, earnings, balance sheet effects, guidance changes, or other metrics provided.

04-02-2026

Revolve Group, Inc. filed an 8-K on 2026-02-04 reporting Item 1.01 (Entry into a Material Definitive Agreement) and Item 2.03 (Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant). Item 9.01 discloses Financial Statements and Exhibits. No transaction details, dollar values, financial metrics, or impacts are provided.

04-02-2026

Firefly Neuroscience, Inc. filed an 8-K on 2026-02-04 disclosing entry into a material definitive agreement under Item 1.01 and departure/election of directors or certain officers, including compensatory arrangements of certain officers under Item 5.02. Item 9.01 includes financial statements and exhibits. No specific transaction details, financial metrics, or quantitative impacts are disclosed.

04-02-2026

Greenbrier Companies Inc filed an 8-K on February 4, 2026, reporting under Item 1.01 entry into a material definitive agreement, under Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement, under Item 7.01 Regulation FD disclosure, and under Item 9.01 financial statements and exhibits. No specific details on the nature of the agreement, transaction size, parties involved, financial terms, or impacts are disclosed in the provided filing summary. No quantitative metrics, period-over-period comparisons, or scheduled events are mentioned.

04-02-2026

GenFlat Holdings, Inc. filed an 8-K on February 4, 2026, disclosing under Item 1.01 entry into a Material Definitive Agreement, Item 7.01 Regulation FD Disclosure, and Item 9.01 Financial Statements and Exhibits. No specific details on the agreement, transaction size, financial impacts, or other metrics are provided in the available information. This is a multi-item filing with no quantitative data or performance metrics disclosed.

04-02-2026

Post Holdings, Inc. filed a Form 8-K on February 4, 2026, disclosing events under Item 3.03 (Material Modifications to Rights of Security Holders), Item 5.03 (Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year), Item 5.07 (Submission of Matters to a Vote of Security Holders), and Item 9.01 (Financial Statements and Exhibits). This multi-item filing reports governance-related changes and outcomes from a shareholder vote, but no specific details, vote results, amendment descriptions, or financial metrics are provided in the available information. No positive or negative performance metrics are mentioned.

04-02-2026

Alliance Resource Partners LP filed an 8-K on 2026-02-04 disclosing under Item 1.01 entry into a material definitive agreement. Item 9.01 provides for financial statements and exhibits, likely including the agreement document. No specific details on the agreement terms, transaction value, parties, financial impacts, or metrics are disclosed.

04-02-2026

WRAP Technologies, Inc. filed a Form 8-K on February 4, 2026, reporting under Item 1.01 entry into a material definitive agreement, under Item 3.02 unregistered sales of equity securities, under Item 8.01 other events, and under Item 9.01 financial statements and exhibits. No specific details, dollar values, share counts, or financial impacts for these items are disclosed. This is a multi-item filing with no period-over-period comparisons or guidance provided.

04-02-2026

Stifel Financial Corp filed an 8-K on February 4, 2026, reporting under Item 1.01 entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement. Item 9.01 discloses financial statements and exhibits. No specific transaction details, dollar values, financial metrics, positive or negative impacts, or period-over-period comparisons are provided.

04-02-2026

Adial Pharmaceuticals, Inc. filed an 8-K on February 4, 2026, reporting under Item 3.03 material modifications to rights of security holders, under Item 5.03 amendments to articles of incorporation or bylaws or change in fiscal year, under Item 8.01 other events, and under Item 9.01 financial statements and exhibits. This is a multi-item filing with no specific details, transaction values, financial metrics, positive or negative changes, or period-over-period comparisons disclosed. No quantitative impacts or directional biases are evident from the available information.

04-02-2026

Maze Therapeutics, Inc. filed a Form 8-K on February 04, 2026, reporting entry into a new material definitive agreement under Item 1.01, termination of a prior material definitive agreement under Item 1.02, and creation of a direct financial obligation or off-balance sheet arrangement under Item 2.03. This multi-item filing signals significant contractual changes and new obligations, but no specific details, dollar values, or strategic context were disclosed. The combination suggests potential strategic shifts offset by new financial commitments.

04-02-2026

Uniti Group Inc. filed an 8-K on February 4, 2026, disclosing under Item 1.01 entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or an obligation under an off-balance sheet arrangement. Item 9.01 provides financial statements and exhibits. No specific transaction details, dollar values, or financial impacts are disclosed.

04-02-2026

SiTime Corp filed a Form 8-K on February 4, 2026 (AccNo: 0001193125-26-037802, Size: 6 MB), reporting under Item 1.01 entry into a material definitive agreement, under Item 7.01 Regulation FD disclosure, and under Item 9.01 financial statements and exhibits. This is a multi-item mandatory filing for the material agreement, with Regulation FD potentially voluntary if triggered. No specific details on the agreement terms, transaction value, financial impacts, or quantitative metrics are disclosed in the provided filing summary.

04-02-2026

CION Investment Corp filed an 8-K on February 4, 2026, disclosing under Item 1.01 entry into a material definitive agreement and under Item 9.01 financial statements and exhibits. No details on the agreement's parties, terms, value, or financial implications are provided. This is a multi-item mandatory filing with no quantitative metrics or performance comparisons disclosed.

04-02-2026

UPEXI, INC. filed an 8-K on February 4, 2026, reporting under Item 1.01 entry into a material definitive agreement and under Item 9.01 financial statements and exhibits. No details on the agreement terms, transaction value, parties involved, financial impacts, or other metrics are disclosed in the provided filing summary. This represents a mandatory disclosure of a material event without quantitative data or directional implications.

04-02-2026

Vivakor, Inc. filed an 8-K on February 4, 2026, disclosing entry into a material definitive agreement under Item 1.01 and unregistered sales of equity securities under Item 3.02, accompanied by financial statements and exhibits under Item 9.01. This is a multi-item mandatory filing with no specific transaction details, dollar values, or financial impacts provided. No quantitative metrics, period-over-period comparisons, or guidance changes are mentioned.

04-02-2026

Oracle Corp filed a Form 8-K on 2026-02-04 reporting entry into a material definitive agreement under Item 1.01, other events under Item 8.01, and financial statements and exhibits under Item 9.01. This is a multi-item filing with no specific details provided on the agreement, events, transaction value, financial impacts, or metrics. No quantitative data, period-over-period comparisons, or scheduled events are disclosed.